About
This medication is a combination therapy for type 2 diabetes mellitus, typically containing a sulfonylurea (like Gliclazide) and Metformin. Gliclazide works by stimulating the pancreatic beta cells to release insulin, thereby lowering blood glucose. Metformin, a biguanide, acts primarily by reducing hepatic glucose production, decreasing intestinal glucose absorption, and improving insulin sensitivity in peripheral tissues. The combination provides a synergistic effect, targeting multiple pathways involved in glucose regulation, leading to more effective glycemic control than either agent alone. The "OD" formulation suggests an extended-release preparation, designed for once-daily dosing to provide sustained blood sugar management. This dual-action approach helps to address different aspects of insulin resistance and impaired insulin secretion, which are hallmarks of type 2 diabetes. It is prescribed when diet, exercise, and monotherapy with either agent are insufficient to achieve target blood glucose levels, offering a more robust solution for glycemic management and reducing the risk of diabetes-related complications.
Uses
- Management of Type 2 Diabetes Mellitus.
- To improve glycemic control in adults.
- Used when monotherapy is inadequate.
- As an adjunct to diet and exercise.
Directions For Use
Take this medication orally, usually once daily with a meal, preferably the evening meal for OD formulations. Swallow the tablet whole; do not crush, chew, or break it.
Benefits
- Comprehensive blood glucose control.
- Targets multiple mechanisms of action.
- Convenient once-daily dosing (for OD formulations).
- Reduces risk of long-term diabetes complications.
- Potentially lower risk of hypoglycemia compared to sulfonylurea monotherapy.
- May aid in weight management (Metformin component).
Side Effects
- Hypoglycemia (less common than sulfonylurea alone)
- Nausea
- Diarrhea
- Abdominal discomfort
- Metallic taste in mouth
- Headache
- Dizziness
- Lactic acidosis (rare but serious, Metformin-related)
- Vitamin B12 deficiency (Metformin-related)
- Skin rash
- Weight gain (less common than sulfonylurea alone)
- Indigestion
Safety Measures
- Alcohol - Alcohol can increase the risk of lactic acidosis (due to Metformin) and hypoglycemia (due to sulfonylurea). Avoid excessive alcohol consumption.
- Pregnancy - Generally not recommended during pregnancy. Consult a doctor as insulin therapy is often preferred for glycemic control in pregnant women.
- Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and cause adverse effects in the infant.
- Liver - Contraindicated in severe liver impairment due to increased risk of lactic acidosis (Metformin) and hypoglycemia (sulfonylurea). Use with extreme caution in mild to moderate impairment.
- Kidney - Contraindicated in severe kidney impairment (eGFR <30 mL/min/1.73m²) due to increased risk of lactic acidosis (Metformin). Dose adjustment is required for moderate impairment.
- Lung - No specific contraindications or major safety concerns directly related to chronic lung conditions are typically associated with this medication, but acute respiratory failure can increase lactic acidosis risk.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!